Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 8-K Event Other events
  2. 8-A12B Other Registration of Securities
  3. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
  4. 8-K Event Material agreement · Agreement ended · New debt or obligation
  5. 424B5 Offering Prospectus
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market buy Director bought 2,200 shares at $2.29 ($5,038)
  9. 4 Open-market buy Director bought 5,000 shares at $2.22 ($11,100)
  10. 4 Open-market buy EVP, CSO and CMO bought 4,000 shares at $2.20 ($8,800)
  11. 4 Open-market buy President and CEO bought 4,000 shares at $2.24 ($8,960)
  12. 8-K Event Other events
  13. 4 Open-market buy Director bought 5,300 shares at an average $2.56 ($13,586)
  14. 4 Open-market buy Director bought 2,000 shares at $2.88 ($5,760)
  15. 4 Open-market buy Director bought 10,200 shares at an average $2.89 ($29,499)
  16. 4 Open-market buy President and CEO bought 6,000 shares at an average $3.04 ($18,260)
  17. 4 Open-market buy EVP, CFO bought 4,000 shares at $2.97 ($11,860)
  18. 4 Open-market buy EVP, CSO and CMO bought 7,000 shares at an average $2.88 ($20,150)
  19. 424B5 Offering Prospectus
  20. 10-Q Report Quarterly Report

Page 21 of 50 · 1,000 filings